Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

ER+ Breast Cancer: Beyond Oestrogen with Tanya Wells

ER+ Breast Cancer: Beyond Oestrogen with Tanya Wells

FromFX Medicine Podcast Central


ER+ Breast Cancer: Beyond Oestrogen with Tanya Wells

FromFX Medicine Podcast Central

ratings:
Length:
20 minutes
Released:
Jan 28, 2020
Format:
Podcast episode

Description

Oestrogen receptor-positive (ER+) breast cancer is the most common type of breast cancer. It accounts for over two thirds of all breast cancer cases. But what does ER+ actually mean? And if all women have oestrogen, why doesn't every woman get breast cancer?  Tanya Wells is a naturopath whose expertise is in designing integrative oncology programs that utilise the best evidence-based complementary therapies to support conventional treatments. Today, Tanya takes us through the role of ER+ breast cancer, oestrogen metabolism, relevant genetics and how to support patients to prevent recurrence when in remission. Find today's show notes and transcript here: https://www.fxmedicine.com.au/podcast/er-breast-cancer-beyond-oestrogen-tanya-wells *****DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.*****
Released:
Jan 28, 2020
Format:
Podcast episode

Titles in the series (100)

FX Medicine is at the forefront of ensuring functional and integrative medicine gains the recognition it deserves and ultimately establishes itself as an integral part of standard medical practice. Our podcasts are designed to promote research and evidence based therapeutic practises, acting as a progressive force for change and improvement in patient health and wellbeing.